发明名称 HETEROCYCLIC ACETAMIDE COMPOUND
摘要 [Problem] A compound which is useful as a dopamine D1 receptor positive allosteric modulator (D1 PAM) is provided. [Means for Solution] The present inventors have studied a compound which has a dopamine D1 receptor positive allosteric modulating activity and is useful as an active ingredient of a pharmaceutical composition for preventing and/or treating cognitive impairment, negative symptoms of schizophrenia, Parkinson's disease, Alzheimer's disease, Huntington's disease, drug addictions, or the like, and they have thus found that a heterocyclic acetamide compound has a dopamine D1 receptor positive allosteric modulating activity, thereby completing the present invention. The heterocyclic acetamide compound of the present invention has a dopamine D1 receptor positive allosteric modulating activity and can be used as an agent for preventing and/or treating cognitive impairment, negative symptoms of schizophrenia, Parkinson's disease, Alzheimer's disease, Huntington's disease, drug addictions, or the like.
申请公布号 SG11201508448R(A) 申请公布日期 2015.11.27
申请号 SG11201508448R 申请日期 2014.04.18
申请人 ASTELLAS PHARMA INC. 发明人 SHIRAKI, RYOTA;TOBE, TAKAHIKO;KAWAKAMI, SHIMPEI;MORITOMO, HIROYUKI;OHMIYA, MAKOTO
分类号 C07D413/12;A61K31/423;A61K31/428;A61K31/498;A61P25/14;A61P25/16;A61P25/28;A61P25/36;C07D403/12;C07D417/12 主分类号 C07D413/12
代理机构 代理人
主权项
地址